Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (29425)	11/19/1999 2:48:00 AM
From: Cheryl Galt	Respond to of 32384

Hi Torben >Besides, I was a bit miffed earlier when they offered this kind of preferential exercise price to a single entity. < Actually, they did this twice. The first was mentioned in a December press release, and the second (last May) was mentioned only in the 2Q99 sec report. 3.6M left is terribly thin, quite ILL-liquid -- and after this exercise I would be most uncomfortable holding them. Gambling is not in my blood ... --------------- > I see no reason whatsoever not to take the offer and exercise early. < I wonder if everyone holding them has the $6/share needed for converting them. Those who don't -- or who don't want to convert -- are likely to be trading them soon. > Hey, if nothing else, I will now get an annual report :-) You don't get one if you only hold the warrants! < I didn't know that! However, the bulk of Ligand's website is actually the annual report, page for page, word for word. And in the web format, you can find things using <Find> and searches -- so it's more convenient. --------------- I'll be happy to see the demise of the warrants. Regards, Cheryl